SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-005819
Filing Date
2023-04-03
Accepted
2023-04-03 17:46:26
Documents
1
Period of Report
2023-03-30

Document Format Files

Seq Description Document Type Size
1 form3-04032023_090415.html 3  
1 form3-04032023_090415.xml 3 10917
  Complete submission text file 0001415889-23-005819.txt   12348
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address
Kim Bobae (Reporting) CIK: 0001959158 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36845 | Film No.: 23794127